Quanex Building Products CORP (NX) stock analysis
Close on Nov 11, 2026Market cap $961.89MP/E 21.2Yield 1.52%
StockData Score
Prices as of Nov 11, 2026How the score works
Mixed12 of 30 checks passed
Quanex Building Products passes 12 of the 30 checks behind our score; 4 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 3/6
- Growth
- 2/6
- Past performance
- 1/6
- Financial health
- 2/6
- Dividend
- 4/6
What stands out
Trading below fair value
The share price of $20.99 is below our fair value estimate of $21.94.
Revenue growing 10%+ a year
Revenue grew 14.6% a year over the last three fiscal years.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 21.9% of total debt.
P/E below the industry
Quanex Building Products's P/E of 21.2 is below the Rolling, Drawing, and Extruding of Nonferrous median of 22.3.
What to watch
Margin of safety under 20%
The price is 4.3% below fair value, less than the 20% cushion we look for.
Return on equity under 15%
Return on equity was 6.2% over the last twelve months and averaged 5.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 6.5%, below the 10% that usually covers the cost of capital.
High debt
Debt is 89.0% of shareholders' equity, above the 40% we consider low.
Valuation3/6
P/E above its 5-year median
Quanex Building Products's P/E of 21.2 is above its own 5-year median of 12.0.
P/E below the industry
Quanex Building Products's P/E of 21.2 is below the Rolling, Drawing, and Extruding of Nonferrous median of 22.3.
EV/EBITDA above its 5-year median
Quanex Building Products's EV/EBITDA of 7.5 is above its 5-year median of 6.7.
P/B below the industry
Quanex Building Products's price-to-book of 1.29 is below the Rolling, Drawing, and Extruding of Nonferrous median of 3.17.
Trading below fair value
The share price of $20.99 is below our fair value estimate of $21.94.
Margin of safety under 20%
The price is 4.3% below fair value, less than the 20% cushion we look for.
Growth2/6
Revenue growing 10%+ a year
Revenue grew 14.6% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 1.3% over the last twelve months; the Rolling, Drawing, and Extruding of Nonferrous median is 18.3%.
Guidance issued
The latest outlook (fiscal 2026 net sales, Mar 5, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 26.6% over the last twelve months, against 26.0% a year earlier.
Past performance1/6
Return on equity under 15%
Return on equity was 6.2% over the last twelve months and averaged 5.3% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 6.5%, below the 10% that usually covers the cost of capital.
Return on equity below the industry
Quanex Building Products's return on equity of 6.2% is below the Rolling, Drawing, and Extruding of Nonferrous median of 15.6%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 2.4% over the last twelve months, against a 5-year average of 1.8%.
Net margin below the industry
Quanex Building Products's net margin of 2.4% is below the Rolling, Drawing, and Extruding of Nonferrous median of 5.2%.
Financial health2/6
High debt
Debt is 89.0% of shareholders' equity, above the 40% we consider low.
Debt rising against equity
Debt to equity rose from 33.0% five years ago to 89.0%.
Debt covered by cash flow
Operating cash flow over the last twelve months equals 21.9% of total debt.
Interest not well covered
Operating income covers interest expense 2.2 times; we look for at least 5.
Short-term assets cover short-term debts
Current assets are 2.23 times current liabilities.
Bankruptcy risk in the grey zone
The Altman Z-score is 1.93; above 3 is the safe zone and below 1.8 the distress zone.
Dividend4/6
Pays a dividend
Quanex Building Products paid dividends worth 1.5% of the share price over the last twelve months.
Yield below Treasuries
The 1.5% yield is below the 4.4% on a 1-year Treasury.
Yield below the top quarter
The top quarter of US dividend payers yield 3.8% or more; Quanex Building Products yields 1.5%.
Dividend not cut
The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.
Covered by earnings
Dividends take 32.1% of net income.
Covered by free cash flow
Dividends take 16.0% of free cash flow.
Fair value
How we estimate itOur estimate per share
$21.94
The share price is 4% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 17.1× | 12.0× | 22.3× | $16.94 | 40% |
| EV/EBITDA | 8.2× | 6.7× | 9.7× | $24.39 | 35% |
| P/B | 2.4× | 1.6× | 3.2× | $38.69 | 10% |
| Earnings power | 10.4% cost of equity | – | – | $18.43 | 15% |
| Fair value | $21.94 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 12.0
- Rolling, Drawing, and Extruding of Nonferrous median 22.3
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Medium risk
- Average value traded per day
- $8.01M
- Value traded per 1% price move
- $3.11M
Downside
Medium risk
- Typical loss in a bad month
- 22.7%
- Volatility (annualized)
- 56%
- Sharpe ratio, 1 year
- 0.98
- Beta to the S&P 500 (5Y)
- 1.11
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +43.8% | +14.6% | +16.6% | +11.0% | |
| Gross profit | +63.3% | +23.0% | +21.0% | +13.0% | |
| Free cash flow | +97.7% | +16.4% | +6.4% | +10.7% | |
| Dividend per share | 0.0% | 0.0% | 0.0% | +7.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | -0.5% | 11.2% | -28.9% | |
| Return on assets | -0.3% | 5.8% | -11.7% | |
| Current ratio | 1.79 | 1.59 | 2.04 | |
| Debt to equity | 0.73 | 0.33 | 0.95 | |
| Net debt to EBITDA | 2.73× | 0.64× | -6.81× | |
| Interest coverage | 1.0× | 10.5× | -3.5× | |
| Inventory turnover | 9.6× | 10.3× | 5.1× | |
| Capex to revenue | 4.0% | 3.0% | 3.4% | |
| Diluted shares | 34M | 33M | 46M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Quanex Building Products generated $577.31M from operations and spent $308.86M on capital expenditure, dividends and share buybacks. 63% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -13.6% | 0.86× | 2.47× | -28.9% |
| FY2024 | 2.6% | 0.81× | 2.02× | 4.2% |
| FY2023 | 7.3% | 1.45× | 1.54× | 16.3% |
| FY2022 | 7.2% | 1.69× | 1.63× | 20.0% |
| FY2021 | 5.3% | 1.52× | 1.82× | 14.7% |
| FY2020 | 4.5% | 1.27× | 1.95× | 11.2% |
| FY2019 | -5.2% | 1.29× | 1.91× | -12.9% |
| FY2018 | 3.0% | 1.17× | 1.89× | 6.6% |
| FY2017 | 2.2% | 1.12× | 2.00× | 4.8% |
| FY2016 | -0.2% | 1.38× | 1.76× | -0.5% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero-$250.81M
- Cash generatingOperating cash flow above zero$164.90M
- Return on assets improvedROA up on the prior year4.0% → -10.8%
- Earnings backed by cashOperating cash flow above net income$164.90M vs -$250.81M
- Less leverageLong-term debt to assets fell31.8% → 33.8%
- Better liquidityCurrent ratio rose2.24 → 2.04
- No dilutionShare count did not rise37M → 46M
- Gross margin improvedGross margin up on the prior year23.92% → 27.17%
- More efficientAsset turnover rose1.54 → 0.79
See a number that looks wrong?